The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

Summary

In this study, perioperative propranolol β-blockade was administered to patients with surgically resectable primary gastrointestinal tumors to explore the safety, efficacy, and alleviation of perioperative psychological stress. At the same time, a multi-omics study was conducted using clinical samples to explore the activation of anti-tumor immune response and its mechanism.

Timeline

Start

2024-12-01

Primary completion

2026-12-31

Completion

2027-04-30

Drugs

Indications